Structure of CrmE, a Virus-encoded Tumour Necrosis Factor Receptor

Journal of Molecular Biology

Volumn 372, Issue 3, 2007, Pages 660-671

  Graham, Stephen C ^a   Bahar, Mohammad W ^a   Abrescia, Nicola G A ^a   Smith, Geoffrey L ^b   Stuart, David I ^a   Grimes, Jonathan M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

immune modulation; poxvirus; tumour necrosis factor (TNF); tumour necrosis factor receptor (TNFR); vaccinia virus

Indexed keywords

CYTOKINE RESPONSE MODIFIER E; LYMPHOTOXIN; PROTEIN TNFRSF1A; PROTEIN TNFRSF1B; RECEPTOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; COMPLEX FORMATION; DIMERIZATION; ESCHERICHIA COLI; LIGAND BINDING; NONHUMAN; POXVIRUS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN PURIFICATION; PROTEIN STRUCTURE; VACCINIA VIRUS; VIRUS STRAIN;

ESCHERICHIA COLI; MAMMALIA; POXVIRIDAE; VACCINIA VIRUS; VARIOLA VIRUS;

EID: 34548230092     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2007.06.082     Document Type: Article

References (59)

1. Taylor J.M., and Barry M. Near death experiences: poxvirus regulation of apoptotic death. Virology 344 (2006) 139-150
2. Haga I.R., and Bowie A.G. Evasion of innate immunity by vaccinia virus. Parasitology 130 (2005) S11-S25 (Suppl.)
3. Seet B.T., Johnston J.B., Brunetti C.R., Barrett J. W., Everett H., Cameron C., et al. Poxviruses and immune evasion. Annu. Rev. Immunol. 21 (2003) 377-423
4. Alcami A. Viral mimicry of cytokines, chemokines and their receptors. Nature Rev. Immunol. 3 (2003) 36-50
5. Ware C.F. Network communications: lymphotoxins, LIGHT, and TNF. Annu. Rev. Immunol. 23 (2005) 787-819
6. Idriss H.T., and Naismith J.H. TNF alpha and the TNF receptor superfamily: structure-function relationship(s). Microsc. Res. Tech. 50 (2000) 184-195
7. Sambhi S.K., Kohonen-Corish M.R., and Ramshaw I. A. Local production of tumor necrosis factor encoded by recombinant vaccinia virus is effective in controlling viral replication in vivo. Proc. Natl Acad. Sci. USA 88 (1991) 4025-4029
8. Reading P.C., Khanna A., and Smith G.L. Vaccinia virus CrmE encodes a soluble and cell surface tumor necrosis factor receptor that contributes to virus virulence. Virology 292 (2002) 285-298
9. Upton C., Macen J.L., Schreiber M., and McFadden G. Myxoma virus expresses a secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to viral virulence. Virology 184 (1991) 370-382
10. Smith R.A., and Baglioni C. The active form of tumor necrosis factor is a trimer. J. Biol. Chem. 262 (1987) 6951-6954
11. Aggarwal B.B. Signalling pathways of the TNF superfamily: a double-edged sword. Nature Rev. Immunol. 3 (2003) 745-756
12. Locksley R.M., Killeen N., and Lenardo M.J. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104 (2001) 487-501
13. Bodmer J.L., Schneider P., and Tschopp J. The molecular architecture of the TNF superfamily. Trends Biochem. Sci. 27 (2002) 19-26
14. Zhang G. Tumor necrosis factor family ligand-receptor binding. Curr. Opin. Struct. Biol. 14 (2004) 154-160
15. Banner D.W., D'Arcy A., Janes W., Gentz R., Schoenfeld H.J., Broger C., et al. Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation. Cell 73 (1993) 431-445
16. Cunnion K.M. Tumor necrosis factor receptors encoded by poxviruses. Mol. Genet. Metab. 67 (1999) 278-282
17. Saraiva M., and Alcami A. CrmE, a novel soluble tumor necrosis factor receptor encoded by poxviruses. J. Virol. 75 (2001) 226-233
18. Brunetti C.R., Paulose-Murphy M., Singh R., Qin J., Barrett J.W., Tardivel A., et al. A secreted high-affinity inhibitor of human TNF from Tanapox virus. Proc. Natl Acad. Sci. USA 100 (2003) 4831-4836
19. Rahman M.M., Barrett J.W., Brouckaert P., and McFadden G. Variation in ligand binding specificities of a novel class of poxvirus-encoded tumor necrosis factor-binding protein. J. Biol. Chem. 281 (2006) 22517-22526
20. Naismith J.H., and Sprang S.R. Modularity in the TNF-receptor family. Trends Biochem. Sci. 23 (1998) 74-79
21. Hu F.Q., Smith C.A., and Pickup D.J. Cowpox virus contains two copies of an early gene encoding a soluble secreted form of the type II TNF receptor. Virology 204 (1994) 343-356
22. Smith C.A., Hu F.Q., Smith T.D., Richards C.L., Smolak P., Goodwin R.G., and Pickup D.J. Cowpox virus genome encodes a second soluble homologue of cellular TNF receptors, distinct from CrmB, that binds TNF but not LT alpha. Virology 223 (1996) 132-147
23. Loparev V.N., Parsons J.M., Knight J.C., Panus J.F., Ray C.A., Buller R.M., et al. A third distinct tumor necrosis factor receptor of orthopoxviruses. Proc. Natl Acad. Sci. USA 95 (1998) 3786-3791
24. Panus J.F., Smith C.A., Ray C.A., Smith T.D., Patel D.D., and Pickup D.J. Cowpox virus encodes a fifth member of the tumor necrosis factor receptor family: a soluble, secreted CD30 homologue. Proc. Natl Acad. Sci. USA 99 (2002) 8348-8353
25. Alejo A., Ruiz-Arguello M.B., Ho Y., Smith V.P., Saraiva M., and Alcami A. A chemokine-binding domain in the tumor necrosis factor receptor from variola (smallpox) virus. Proc. Natl Acad. Sci. USA 103 (2006) 5995-6000
26. Smith C.A., Davis T., Wignall J.M., Din W.S., Farrah T., Upton C., et al. T2 open reading frame from the Shope fibroma virus encodes a soluble form of the TNF receptor. Biochem. Biophys. Res. Commun. 176 (1991) 335-342
27. Alcami A., Khanna A., Paul N.L., and Smith G.L. Vaccinia virus strains Lister, USSR and Evans express soluble and cell-surface tumour necrosis factor receptors. J. Gen. Virol. 80 (1999) 949-959
28. Chan F.K., Chun H.J., Zheng L., Siegel R.M., Bui K.L., and Lenardo M.J. A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling. Science 288 (2000) 2351-2354
29. Sedger L.M., Osvath S.R., Xu X.M., Li G., Chan F.K., Barrett J.W., and McFadden G. Poxvirus tumor necrosis factor receptor (TNFR)-like T2 proteins contain a conserved preligand assembly domain that inhibits cellular TNFR1-induced cell death. J. Virol. 80 (2006) 9300-9309
30. Schneider T.R. A genetic algorithm for the identification of conformationally invariant regions in protein molecules. Acta Crystallog. sect. D 58 (2002) 195-208
31. Kleywegt G.J., and Jones T.A. Detecting folding motifs and similarities in protein structures. Methods Enzymol. 277 (1997) 525-545
32. Marsters S.A., Frutkin A.D., Simpson N.J., Fendly B.M., and Ashkenazi A. Identification of cysteine-rich domains of the type 1 tumor necrosis factor receptor involved in ligand binding. J. Biol. Chem. 267 (1992) 5747-5750
33. Naismith J.H., Devine T.Q., Kohno T., and Sprang S.R. Structures of the extracellular domain of the type I tumor necrosis factor receptor. Structure 4 (1996) 1251-1262
34. Naismith J.H., Devine T.Q., Brandhuber B.J., and Sprang S.R. Crystallographic evidence for dimerization of unliganded tumor necrosis factor receptor. J. Biol. Chem. 270 (1995) 13303-13307
35. Compaan D.M., and Hymowitz S.G. The crystal structure of the costimulatory OX40-OX40L complex. Structure 14 (2006) 1321-1330
36. Mongkolsapaya J., Grimes J.M., Chen N., Xu X.N., Stuart D.I., Jones E.Y., and Screaton G.R. Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation. Nature Struct. Biol. 6 (1999) 1048-1053
37. Hymowitz S.G., Christinger H.W., Fuh G., Ultsch M., O'Connell M., Kelley R.F., et al. Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5. Mol. Cell 4 (1999) 563-571
38. Cha S.S., Kim M.S., Choi Y.H., Sung B.J., Shin N.K., Shin H.C., et al. 2.8 Å resolution crystal structure of human TRAIL, a cytokine with selective antitumor activity. Immunity 11 (1999) 253-261
39. Krissinel E., and Henrick K. Detection of protein assemblies in crystals. In: Berthold M.R., Glen R., Diederichs K., Kohlbacher O., and Fischer I. (Eds). Computational Life Sciences vol. 3695 (2005), Springer-Verlag, Berlin-Heidelberg 163-174
40. Carfi A., Willis S.H., Whitbeck J.C., Krummenacher C., Cohen G.H., Eisenberg R.J., and Wiley D.C. Herpes simplex virus glycoprotein D bound to the human receptor HveA. Mol. Cell 8 (2001) 169-179
41. Mauri D.N., Ebner R., Montgomery R.I., Kochel K.D., Cheung T.C., Yu G.L., et al. LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity 8 (1998) 21-30
42. Loetscher H., Stueber D., Banner D., Mackay F., and Lesslauer W. Human tumor necrosis factor alpha (TNF alpha) mutants with exclusive specificity for the 55-kDa or 75-kDa TNF receptors. J. Biol. Chem. 268 (1993) 26350-26357
43. Jones E.Y., Stuart D.I., and Walker N.P. Structure of tumour necrosis factor. Nature 338 (1989) 225-228
44. Eck M.J., and Sprang S.R. The structure of tumor necrosis factor-alpha at 2.6 Å resolution. Implications for receptor binding. J. Biol. Chem. 264 (1989) 17595-17605
45. Studier F.W. Protein production by auto-induction in high density shaking cultures. Protein Expr. Purif. 41 (2005) 207-234
46. Walter T.S., Diprose J.M., Mayo C.J., Siebold C., Pickford M.G., Carter L., et al. A procedure for setting up high-throughput nanolitre crystallization experiments. Crystallization workflow for initial screening, automated storage, imaging and optimization. Acta Crystallog. sect. D 61 (2005) 651-657
47. Otwinowski Z., and Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276 (1997) 307-326
48. Vonrhein C., Blanc E., Roversi P., and Bricogne G. Automated structure solution with autoSHARP. Methods Mol. Biol. 364 (2006) 215-230
49. Schneider T.R., and Sheldrick G.M. Substructure solution with SHELXD. Acta Crystallog. sect. D 58 (2002) 1772-1779
50. de la Fortelle E., and Bricogne G. Maximum-likelihood heavy-atom parameter refinement for multiple isomorphous replacement and multiwavelength anomalous diffraction methods. Methods Enzymol. 276 (1997) 472-494
51. Terwilliger T.C. Maximum-likelihood density modification using pattern recognition of structural motifs. Acta Crystallog. sect. D. 57 (2001) 1755-1762
52. Cowtan K. General quadratic functions in real and reciprocal space and their application to likelihood phasing. Acta Crystallog. sect. D 56 (2000) 1612-1621
53. Emsley P., and Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallog. sect. D 60 (2004) 2126-2132
54. Blanc E., Roversi P., Vonrhein C., Flensburg C., Lea S.M., and Bricogne G. Refinement of severely incomplete structures with maximum likelihood in BUSTER-TNT. Acta Crystallogr. sect. D 60 (2004) 2210-2221
55. β deviation. Proteins: Struct. Funct. Bioinf. 50 (2003) 437-450
56. Lawrence M.C., and Colman P.M. Shape complementarity at protein/protein interfaces. J. Mol. Biol. 234 (1993) 946-950
57. Katoh K., Kuma K., Toh H., and Miyata T. MAFFT version 5: improvement in accuracy of multiple sequence alignment. Nucl. Acids Res. 33 (2005) 511-518
58. Clamp M., Cuff J., Searle S.M., and Barton G.J. The Jalview Java alignment editor. Bioinformatics 20 (2004) 426-427
59. Cruickshank D.W. Remarks about protein structure precision. Acta Crystallog. sect. D 55 (1999) 583-601